| Ashley Rena Christopher, FNP | |
|
3535 S Interstate 35 E, Denton, TX 76210-6850 | |
| (940) 202-9101 | |
| Not Available |
| Full Name | Ashley Rena Christopher |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 12 Years |
| Location | 3535 S Interstate 35 E, Denton, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649512591 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 757248 (Texas) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | AP123405 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Medical City Denton | Denton, TX | Hospital |
| Texas Health Presbyterian Hospital Denton | Denton, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Id Experts Pllc | 5496059974 | 2 |
News Archive
Governor Edward G. Rendell recognizes the value of good nutrition and regular exercise in promoting good health as he proclaims March 8-12 Older Pennsylvanians' Nutrition Awareness Week.
£1.5m of research funding has been awarded to develop advanced imaging technologies, to maximise their potential to reduce animal use in a diverse range of preclinical research applications.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and collaborators from the Massachusetts Institute of Technology (MIT), The University of British Columbia (UBC), AlCana Technologies, Inc., and Tekmira Pharmaceuticals Corporation, presented results from multiple ongoing research efforts regarding the discovery of novel technologies for the systemic delivery of RNAi therapeutics.
With unexpected findings about a protein that's highly expressed in fat tissue, scientists at Scripps Research have opened the door to critical new understandings about obesity and metabolism.
Arena Pharmaceuticals, Inc. and Eisai Inc. announced today the completion of an end-of-review meeting with the US Food and Drug Administration (FDA) for the lorcaserin New Drug Application (NDA).
› Verified 2 days ago
| Entity Name | Kamran Chaudhry Md Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962793489 PECOS PAC ID: 6103094644 Enrollment ID: O20110727000464 |
News Archive
Governor Edward G. Rendell recognizes the value of good nutrition and regular exercise in promoting good health as he proclaims March 8-12 Older Pennsylvanians' Nutrition Awareness Week.
£1.5m of research funding has been awarded to develop advanced imaging technologies, to maximise their potential to reduce animal use in a diverse range of preclinical research applications.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and collaborators from the Massachusetts Institute of Technology (MIT), The University of British Columbia (UBC), AlCana Technologies, Inc., and Tekmira Pharmaceuticals Corporation, presented results from multiple ongoing research efforts regarding the discovery of novel technologies for the systemic delivery of RNAi therapeutics.
With unexpected findings about a protein that's highly expressed in fat tissue, scientists at Scripps Research have opened the door to critical new understandings about obesity and metabolism.
Arena Pharmaceuticals, Inc. and Eisai Inc. announced today the completion of an end-of-review meeting with the US Food and Drug Administration (FDA) for the lorcaserin New Drug Application (NDA).
› Verified 2 days ago
| Entity Name | Mass Effect Medical Group Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144511353 PECOS PAC ID: 7911176664 Enrollment ID: O20110815000076 |
News Archive
Governor Edward G. Rendell recognizes the value of good nutrition and regular exercise in promoting good health as he proclaims March 8-12 Older Pennsylvanians' Nutrition Awareness Week.
£1.5m of research funding has been awarded to develop advanced imaging technologies, to maximise their potential to reduce animal use in a diverse range of preclinical research applications.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and collaborators from the Massachusetts Institute of Technology (MIT), The University of British Columbia (UBC), AlCana Technologies, Inc., and Tekmira Pharmaceuticals Corporation, presented results from multiple ongoing research efforts regarding the discovery of novel technologies for the systemic delivery of RNAi therapeutics.
With unexpected findings about a protein that's highly expressed in fat tissue, scientists at Scripps Research have opened the door to critical new understandings about obesity and metabolism.
Arena Pharmaceuticals, Inc. and Eisai Inc. announced today the completion of an end-of-review meeting with the US Food and Drug Administration (FDA) for the lorcaserin New Drug Application (NDA).
› Verified 2 days ago
| Entity Name | Id Experts Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972975365 PECOS PAC ID: 5496059974 Enrollment ID: O20160203001030 |
News Archive
Governor Edward G. Rendell recognizes the value of good nutrition and regular exercise in promoting good health as he proclaims March 8-12 Older Pennsylvanians' Nutrition Awareness Week.
£1.5m of research funding has been awarded to develop advanced imaging technologies, to maximise their potential to reduce animal use in a diverse range of preclinical research applications.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and collaborators from the Massachusetts Institute of Technology (MIT), The University of British Columbia (UBC), AlCana Technologies, Inc., and Tekmira Pharmaceuticals Corporation, presented results from multiple ongoing research efforts regarding the discovery of novel technologies for the systemic delivery of RNAi therapeutics.
With unexpected findings about a protein that's highly expressed in fat tissue, scientists at Scripps Research have opened the door to critical new understandings about obesity and metabolism.
Arena Pharmaceuticals, Inc. and Eisai Inc. announced today the completion of an end-of-review meeting with the US Food and Drug Administration (FDA) for the lorcaserin New Drug Application (NDA).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ashley Rena Christopher, FNP Po Box 51241, Denton, TX 76206-1241 Ph: (214) 578-4648 | Ashley Rena Christopher, FNP 3535 S Interstate 35 E, Denton, TX 76210-6850 Ph: (940) 202-9101 |
News Archive
Governor Edward G. Rendell recognizes the value of good nutrition and regular exercise in promoting good health as he proclaims March 8-12 Older Pennsylvanians' Nutrition Awareness Week.
£1.5m of research funding has been awarded to develop advanced imaging technologies, to maximise their potential to reduce animal use in a diverse range of preclinical research applications.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and collaborators from the Massachusetts Institute of Technology (MIT), The University of British Columbia (UBC), AlCana Technologies, Inc., and Tekmira Pharmaceuticals Corporation, presented results from multiple ongoing research efforts regarding the discovery of novel technologies for the systemic delivery of RNAi therapeutics.
With unexpected findings about a protein that's highly expressed in fat tissue, scientists at Scripps Research have opened the door to critical new understandings about obesity and metabolism.
Arena Pharmaceuticals, Inc. and Eisai Inc. announced today the completion of an end-of-review meeting with the US Food and Drug Administration (FDA) for the lorcaserin New Drug Application (NDA).
› Verified 2 days ago
Shannon L Mckeown, RN, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 535 S Loop 288 Ste 1003, Denton, TX 76205 Phone: 940-349-2900 | |
Jessie Rulan Sherrard, AGACNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3537 S I 35 E Ste 305, Denton, TX 76210 Phone: 940-384-4599 | |
Cornelia Alinnor, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2809 S Mayhill Rd, Denton, TX 76208 Phone: 940-215-0376 | |
Miss Betty Ann Johansen, RN,C,FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3304 Colorado Blvd Ste 101, Denton, TX 76210 Phone: 940-566-2358 Fax: 940-381-2613 | |
Greta Jo Kissel, AGACNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2505 Scripture St Ste 100, Denton, TX 76201 Phone: 940-323-3655 | |
Nongnuch Kuligowski, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2200 W University Dr Ste 150, Denton, TX 76201 Phone: 940-304-0189 | |
Laura A Cronin, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3000 N Interstate 35, Denton, TX 76201 Phone: 940-898-7000 |